Cancer BiologyBiomedicinesPeer-reviewed
Bivalent CD47 Immunotoxin for Targeted Therapy of Lung Cancer
Jihong Ma, Dinoop Ravindran Menon, Zhaohui Wang…·Zhirui Wang
This study develops a bivalent CD47 immunotoxin for NSCLC therapy, showing strong preclinical efficacy in multiple mouse models.
DOI 10.3390/biomedicines14102180